Increasing Drug Makers’ Coverage-Gap Discounts Would Lower Premiums

February 08, 2018
Senators tout their budget deal for closing the Part D donut hole a year early, but the more significant result of the bill for beneficiaries is that it would lower drug premiums, according to Jack Hoadley, a congressional Medicare adviser and policy analyst for Georgetown University’s Health Policy Institute. Although the Part D measure is considered a major loss for drug makers, the bill also would repeal the Independent Payment Advisory Board, which removes the potential for pay cuts to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.